跳至主要内容
临床试验/NCT00526383
NCT00526383已完成不适用

Do Antidepressants Induce Metabolic Syndromes

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 624 人开始时间: 2007年11月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
624
试验地点
1
主要终点
Definition criteria of the metabolic syndromes: Weight and waist circumference Systolic and diastolic blood pressure Glycemia Triglyceridemia Cholesterolemia Insulinemia

研究概览

简要总结

Since antidepressants and antipsychotics have common receptorial mechanisms of action (H1 antagonism, 5HT2 antagonism), the impact of antidepressants in terms of metabolic syndromes is a matter of concern.

The main objective of this study is to assess the differential impact of antidepressants in terms of weight gain and metabolic syndromes.

详细描述

Since antidepressants and antipsychotics have common receptorial mechanisms of action (H1 antagonism, 5HT2 antagonism), the impact of antidepressants in terms of metabolic syndromes is a matter of concern.

The main objective of this study is to assess the differential impact of antidepressants in terms of weight gain and metabolic syndromes.

Prospective 6-month naturalistic cohort study, comparing 4 classes of antidepressants (SSRIs, SNRIs, TCAs and others) to a control group (ECT and r-TMS), in 600 patients with a major depressive disorder requiring the beginning of either antidepressant or ECT/r-TMS treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age : 18-70
  • Current major depressive episode (Major depressive disorder) based on the MINI interview
  • HAM-D >18
  • Requiring either antidepressant treatment, either ECT or r-TMS (as assessed by the clinician)
  • Signed informed consent

排除标准

  • Bipolar disorder (DSM-IV), Psychotic disorder (DSM-IV), Substance abuse or dependence (DSM-IV)
  • Normothymic treatment
  • Antipsychotic treatment

研究组 & 干预措施

B

Placebo Comparator

干预措施: Tricyclic antidepressants (Drug)

A

Experimental

antidepressant versus medical dispositive

干预措施: Tricyclic antidepressants (Drug)

结局指标

主要结局

Definition criteria of the metabolic syndromes: Weight and waist circumference Systolic and diastolic blood pressure Glycemia Triglyceridemia Cholesterolemia Insulinemia

时间窗: at Months 0, 1, 3, 6

次要结局

  • Antidepressant efficacy (HAM-D, quickIDS-C, quickIDS-SR, CGI)(at Months 0, 1, 3, 6)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验